氯沙坦对大脑蓝斑核中血管紧张素Ⅱ所诱导的高盐摄入的影响

doi:10.3969/j.issn.1006-5725.2025.20.003

摘要/Abstract

摘要：

目的通过观察大脑蓝斑核中血管紧张素Ⅱ（angiotensin Ⅱ， Ang Ⅱ）对高盐摄入的影响作用及其氯沙坦对该作用的影响，探讨限盐策略的有效实施方法。方法应用大脑插管术和脑微量注射法，给大鼠蓝斑核内单独微量注射Ang Ⅱ，和联合微量注射生理盐水（saline）、Ang Ⅱ和血管紧张素Ⅱ1型受体（angiotensin Ⅱ type 1 receptor， AT1R）拮抗剂氯沙坦（losartan），观察不同摄钠模型大鼠高渗氯化钠溶液的摄入量和摄水量的变化；给大鼠蓝斑核内单独微量注射Ang Ⅱ，观察禁水大鼠水摄入量的变化和正常大鼠尿量和尿钠排泄量、水平和垂直活动度的变化。结果无论在给予“禁水-不完全补水（water deprivation-partial rehydration，WD-PR）”模型大鼠，还是在“皮下联合注射呋塞米（furosemide，FURO）与卡托普利（captopril，CAP）（FURO-CAP）”模型大鼠，蓝斑核微量注射0.1、1和10 ng 剂量的Ang Ⅱ引起0.3 mol/L NaCl摄入量和水摄入量都呈剂量相关性增长，而预先注射0.5、5和50 μg剂量的AT1R拮抗剂氯沙坦，以剂量依赖性的方式显著抑制10 ng Ang Ⅱ注射到同一部位所引起的0.3 mol/L NaCl摄入量的增加和水摄入量的增加。与蓝斑核注射saline相比，蓝斑核注射10.0 ng 剂量的Ang Ⅱ显著提高大鼠的水平活动度和垂直活动度，对大鼠肾排泄亦无明显影响。结论氯沙坦能抑制大脑蓝斑核Ang Ⅱ所诱导高盐摄入，可作为控制高血压的限盐策略药物治疗方案中一种有效药物。

关键词: 蓝斑核, 血管紧张素Ⅱ, 氯沙坦, 高盐摄入, 肾排泄, 活动度

Abstract:

Objective By observing the effect of angiotensin Ⅱ in the locus coeruleus of the brain on high salt intake and the impact of losartan on this effect， this study explores effective implementation methods for salt restriction strategies. Methods Brain catheterization and microinjection were used to administer single microinjection of Ang Ⅱ into the locus coeruleus of rats， as well as combined microinjection of saline， Ang Ⅱ， and angiotensin Ⅱ type 1 receptor， AT1R antagonist losartan was used to observe the changes in the intake and water intake of hypertonic sodium chloride solution in rats with different sodium intake models； Single microinjection of Ang Ⅱ into the locus coeruleus of rats was performed to observe changes in water intake in water deprived rats， as well as changes in urine output， sodium excretion， horizontal and vertical activity in normal rats. Results Whether in rats treated with “water deprivation partial rehydration （WD-PR）” or in rats treated with “subcutaneous combined injection of furosemide （FURO） and Captopril （CAP）（FURO-CAP）”， microinjection of 0.1 ng， 1 ng， and 10 ng doses of Ang Ⅱ into the locus coeruleus caused a dose-dependent increase in 0.3 mol/L NaCl intake and water intake. However， pre injection of AT1R antagonist losartan at doses of 0.5 μ g， 5 μ g， and 50 μ g significantly inhibited the injection of 10 ng Ang Ⅱ into the same site in a dose-dependent manner. The increase in intake of 0.3 mol/L NaCl and water caused by it. Compared with injection of saline into the locus coeruleus， injection of 10.0ng dose of Ang Ⅱ into the locus coeruleus significantly increased the horizontal and vertical activity of rats， but had no significant effect on renal excretion. Conclusion Losartan can inhibit the high salt intake induced by Ang Ⅱ in the locus coeruleus of the brain， and can be used as an effective drug in the salt limiting strategy for controlling hypertension.

Key words: locus coeruleus, Ang Ⅱ, losartan, high sodium intake, renal excretion, activity level

中图分类号:

R544.1

闫君宝,陈义祥,牛小艳,陆兆丰. 氯沙坦对大脑蓝斑核中血管紧张素Ⅱ所诱导的高盐摄入的影响[J]. 实用医学杂志, 2025, 41(20): 3155-3164.

Junbao YAN,Yixiang CHEN,Xiaoyan NIU,Zhaofeng. LU. Effect of losartan on high salt intake induced by angiotensin Ⅱ in the locus coeruleus of the brain[J]. The Journal of Practical Medicine, 2025, 41(20): 3155-3164.

图/表 15

图1

图2

图3

图4

图5

图6

图7

图8

图9

图10

图11

图12

图13

图14

图15

参考文献 27

[1]	中华医学会心血管病学分会，中华心血管病杂志编辑委员会.盐敏感性高血压管理的中国专家共识［J］.中华心血管病杂志，2023，51（4）：364-376.
[2]	TAKIMOTO-OHNISHI E， MURAKAMI K. Renin-angiotensin system research： from molecules to the whole body［J］. J Physiol Sci，2019，69（4）：581-587. doi:10.1007/s12576-019-00679-4 doi: 10.1007/s12576-019-00679-4
[3]	刘立天，王家琦，谢悦陶，等.沙库巴曲缬沙坦对慢性心力衰竭兔心室重构的影响［J］.实用医学杂志. 2022， 38（10）：1193-1197.
[4]	骆骏骞，邓志文，黎土娣，等.心力衰竭的治疗进展［J］.实用医学杂志，2022， 38（10）： 1181-1186. doi:10.3969/j.issn.1006-5725.2022.10.002 doi: 10.3969/j.issn.1006-5725.2022.10.002
[5]	刘房春，何东旭，张健. 沙库巴曲缬沙坦钠在急性心肌梗死患者中的疗效和安全性［J］.实用医学杂志，2022， 38 （8）： 938-942.
[6]	POE G R， FOOTE S， ESCHENKO O，et al. Locus coeruleus：a new look at the blue spot［J］. Nat Rev Neurosci，2020，21（11）：644-659. doi:10.1038/s41583-020-0360-9 doi: 10.1038/s41583-020-0360-9
[7]	MATT R A， MARTIN R S， EVANS A K，et al. Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease［J］. Handb Exp Pharmacol，2024，285：555-616. doi:10.1007/164_2023_677 doi: 10.1007/164_2023_677
[8]	MA H T， ZHANG H C， ZUO Z F，et al. Heterogeneous organization of Locus coeruleus：An intrinsic mechanism for functional complexity［J］. Physiol Behav，2023，268：114231. doi:10.1016/j.physbeh.2023.114231 doi: 10.1016/j.physbeh.2023.114231
[9]	TSUKAHARA J S， ENGLE R W. Fluid intelligence and the locus coeruleus-norepinephrine system［J］. Proc Natl Acad Sci U S A，2021，118（46）：e2110630118. doi:10.1073/pnas.2110630118 doi: 10.1073/pnas.2110630118
[10]	NIKOLENKO V N， BORMINSKAYA I D， NIKITINA A T，et al. Locus Coeruleus-Norepinephrine System：Spheres of Influence and Contribution to the Development of Neurodegenerative Diseases［J］. Front Biosci （Landmark Ed），2024，29（3）：118. doi:10.31083/j.fbl2903118 doi: 10.31083/j.fbl2903118
[11]	MCBURNEY-LIN J， VARGOVA G， GARAD M，et al. The locus coeruleus mediates behavioral flexibility［J］. Cell Rep，2022，41（4）：111534. doi:10.1016/j.celrep.2022.111534 doi: 10.1016/j.celrep.2022.111534
[12]	PISANI F， PISANI V， ARCANGELI F，et al. Locus Coeruleus Dysfunction and Trigeminal Mesencephalic Nucleus Degeneration：A Cue for Periodontal Infection Mediated Damage in Alzheimer's Disease？［J］. Int J Environ Res Public Health，2023，20（2）：1007. doi:10.3390/ijerph20021007 doi: 10.3390/ijerph20021007
[13]	MATT R A， MARTIN R S， EVANS A K，et al. Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease［J］. Handb Exp Pharmacol，2024，285：555-616. doi:10.1007/164_2023_677 doi: 10.1007/164_2023_677
[14]	LEE S， AUGUSTINE V， ZHAO Y，et al. Chemosensory modulation of neural circuits for sodium appetite［J］. Nature，2019，568（7750）：93-97. doi:10.1038/s41586-019-1053-2 doi: 10.1038/s41586-019-1053-2
[15]	诸葛启钏.大鼠脑立体定位仪图谱［M］.北京：人民卫生出版社出版，2005.
[16]	BERNAL A， ZAFRA M A， SIMON M J，et al. Sodium Homeostasis，a Balance Necessary for Life［J］. Nutrients，2023，15（2）：395. doi:10.3390/nu15020395 doi: 10.3390/nu15020395
[17]	XUE B， BELTZ T G， YU Y，et al. Central interactions of aldosterone and angiotensin Ⅱ in aldosterone and angiotensin Ⅱ-induced hypertension［J］. Am J Physiol Heart Circ Physiol，2011，300：H555-H564. doi:10.1152/ajpheart.00847.2010 doi: 10.1152/ajpheart.00847.2010
[18]	RONCARI C F， BARBOSA R M， VENDRAMINI R C，et al. Enhanced angiotensin Ⅱ induced sodium appetite in renovascular hypertensive rats［J］. Peptides，2018，101：82-88. doi:10.1016/j.peptides.2017.12.025 doi: 10.1016/j.peptides.2017.12.025
[19]	GASPARINI S， RESCH J M， NARAYAN S V，et al. Aldosterone-sensitive HSD₂ neurons in mice［J］. Brain Struct Funct，2019，224（1）：387-417. doi:10.1007/s00429-018-1778-y doi: 10.1007/s00429-018-1778-y
[20]	LIU J， YOSTEN G L， JI H，et al. Selective inhibition of angiotensin receptor signaling through Erk_1/2 pathway by a novel peptide［J］. Am J Physiol Regul Integr Comp Physiol，2014，306：R619-R626. doi:10.1152/ajpregu.00562.2013 doi: 10.1152/ajpregu.00562.2013
[21]	RESCH J M， FENSELAU H， MADARA J C，et al. Aldosterone-Sensing Neurons in the NTS Exhibit State-Dependent Pacemaker Activity and Drive Sodium Appetite via Synergy with Angiotensin Ⅱ Signaling［J］. Neuron，2017，96（1）：190-206. doi:10.1016/j.neuron.2017.09.014 doi: 10.1016/j.neuron.2017.09.014
[22]	RONCARI C F， DAVID R B， DE PAULA P M， et al. The lateral parabrachial nucleus and central angiotensinergic mechanisms in the control of sodium intake induced by different stimuli［J］. Behav Brain Res，2017，333：17-26. doi:10.1016/j.bbr.2017.06.020 doi: 10.1016/j.bbr.2017.06.020
[23]	HU B， QIAO H， SUN B，et al. AT1 receptor blockade in the central nucleus of the amygdala attenuates the effects of muscimol on sodium and water intake［J］. Neuroscience，2015，307：302-310. doi:10.1016/j.neuroscience.2015.08.069 doi: 10.1016/j.neuroscience.2015.08.069
[24]	GASPARINI S， MELO M R， NASCIMENTO P A，et al. Interaction of central angiotensin Ⅱ and aldosterone on sodium intake and blood pressure［J］. Brain Res，2019，1720：146299. doi:10.1016/j.brainres.2019.06.018 doi: 10.1016/j.brainres.2019.06.018
[25]	WANG G， COLEMAN C G， CHAN J，et al. Angiotensin Ⅱ slow-pressor hypertension enhances NMDA currents and NOX₂-dependent superoxide production in hypothalamic paraventricular neurons［J］. Am J Physiol Regul Integr Comp Physiol，2013，304（12）：R1096-1106. doi:10.1152/ajpregu.00367.2012 doi: 10.1152/ajpregu.00367.2012
[26]	SONG X A， JIA L L， CUI W，et al. Inhibition of TNF-α in hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by inhibiting neurohormonal excitation in spontaneously hypertensive rats［J］. Toxicol Appl Pharmacol，2014，281（1）：101-108. doi:10.1016/j.taap.2014.09.004 doi: 10.1016/j.taap.2014.09.004
[27]	MARCHESE N A， PAZ M C， CAEIRO X，et al. Angiotensin Ⅱ AT1 receptors mediate neuronal sensitization and sustained blood pressure response induced by a single injection of amphetamine［J］. Neuroscience，2017，340：521-529. doi:10.1016/j.neuroscience.2016.11.006 doi: 10.1016/j.neuroscience.2016.11.006